Hypersensitivity Reactions to Antiepileptic Drugs in Children: Epidemiologic, Pathogenetic, Clinical, and Diagnostic

Semanur Kuyucu1, Jean-Christoph Caubet2

  • 1Department of Pediatric Allergy and Clinical Immunology, Faculty of Medicine, Mersin University, Mersin, Turkey.

Insights

Antiepileptic drug hypersensitivity reactions (DHRs) are a significant concern in children, often linked to aromatic antiepileptic drugs (AEDs). Genetic factors and specific patient characteristics increase the risk of severe DHRs in pediatric populations.

Area of Science:

  • Pediatric Allergy and Immunology
  • Clinical Pharmacology
  • Pharmacogenomics

Background:

  • Epilepsy affects millions of children worldwide, with antiepileptic drugs (AEDs) frequently causing severe drug hypersensitivity reactions (DHRs).
  • Systematic studies on AED hypersensitivity in children are scarce, necessitating a comprehensive review of existing data.

Purpose of the Study:

  • To review and synthesize available data on DHRs to AEDs in children.
  • To identify common culprits, risk factors, diagnostic approaches, and management strategies for AED hypersensitivity in pediatric populations.

Main Methods:

  • A PubMed search was conducted for English-language studies published between January 1990 and June 2017.
  • Data on DHRs to AEDs in children were extracted and analyzed.

Main Results:

  • Aromatic AEDs are frequently implicated in DHRs, despite their widespread use.
  • Multifactorial pathogenesis involving metabolic, genetic (HLA associations, enzyme polymorphisms), and immunologic factors is suggested.
  • Risk factors include young age, polypharmacy, rapid dose escalation, and genetic markers.
  • Patch testing shows diagnostic utility for delayed reactions, with reported cross-reactivity rates between aromatic AEDs.

Conclusions:

  • AED hypersensitivity in children is complex, influenced by genetic and environmental factors.
  • Continued surveillance and research into diagnostic tools and management, including desensitization, are crucial for pediatric patients.
  • Despite presumed lower toxicity, newer AEDs require monitoring for severe reactions.

Related Concept Videos

Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
996
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.3K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.8K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.4K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
700
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.8K